Acura Pharma (ACUR) Misses Q1 EPS by 4c

Acura Pharma (NASDAQ: ACUR) reported Q1 EPS of $0.03, $0.04 worse than the analyst estimate of $0.07. Revenue for the quarter came in at $5.4 million versus the consensus estimate of $7.6 million.

For earnings history and earnings-related data on Acura Pharma (ACUR) click here.

You May Also Be Interested In

• Medtronic jumps on earnings beat and raised guidance
• ONEOK Inc (OKE) PT Raised to $95 at Scotiabank
• Ascendis Pharma (ASND) PT Lowered to $304 at BofA Securities